The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Abstract
Gut microbial metabolites, SCFAs, were related with the occurrence and development of Parkinson's disease (PD). But the effects of different short-chain fatty acids (SCFAs) on PD and involving mechanisms are still undefined. In this study we evaluate the effects of three dominant SCFAs (acetate, propionate and butyrate) on motor damage, dopaminergic neuronal degeneration and underlying neuroinflammation related mechanisms in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD mice. High (2.0 g/kg) or low doses (0.2 g/kg) of sodium acetate (NaA), sodium propionate (NaP) or sodium butyrate (NaB) were gavaged into PD mice for 6 weeks. High doses of NaA reduced the turning time of PD mice. NaB significantly reduced the turning and total time in pole test, and increased the average velocity in open field test when compared with PD mice, indicating the most effective alleviation of PD-induced motor disorder. Low and high doses of NaB significantly increased the content of tyrosine hydroxylase (TH) by 12.3% and 20.2%, while reduced α-synuclein activation by 159.4% and 132.7% in the substantia nigra pars compacta (SNpc), compared with PD groups. Butyrate reached into the midbrain SNpc and suppressed microglia over-activation. It inhibited the levels of pro-inflammatory factors (IL-6, IL-1β and TNF-α) (P < 0.01) and iNOS. Besides, butyrate inhibited the activation of NF-κB and MAPK signaling pathways in the SNpc region. Consequently, sodium butyrate could inhibit neuroinflammation and alleviate neurological damage of PD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, studies have demonstrated the neuroprotective effects of sodium butyrate in MPTP-induced PD mice by attenuating microglial reactivity via the inhibition of TLR4/MyD88/NF-κB and MAPK signaling pathway.319–321”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [319]
In the citing paper
“NaB can improve motor symptoms, neuronal loss, and neuroinflammation in MPTP-induced PD mice [23,24,25].”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [23]
Citations
Cites
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Butyrate: A Double-Edged Sword for Health?
Liu, H., Wang, J., He, T., Becker, S. R., Zhang, G., Li, D., & Ma, X. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx009 · Cited by 1,185
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Sun, M., Wu, W. H., Liu, Z., & Cong, Y. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1242-9 · Cited by 1,103
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
Research works printed but not linked: 1
- Cao, 2006, Mechanism of over-activation in direct pathway mediated by dopamine D₁ receptor in rats with levodopa-induced dyskinesia. Neurosci, Bull, 22, 159
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 212
Self-citationGut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177
Self-citationKalyanaraman, B., Cheng, G., & Hardy, M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103092 · Cited by 185
Cao, Q., Shen, M., Li, R., Liu, Y., Zeng, Z., Zhou, J., Niu, D., Zhang, Q., Wang, R., Yao, J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03454-y · Cited by 138
Neurodegenerative disorders and gut-brain interactions
Singh, A., Dawson, T. M., & Kulkarni, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143775 · Cited by 104
Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
Lei, W., Cheng, Y., Gao, J., Liu, X., Shao, L., Kong, Q., Zheng, N., Ling, Z., & Hu, W. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1224155 · Cited by 104
A prebiotic diet modulates microglial states and motor deficits in α-synuclein overexpressing mice
Abdel-Haq, R., Schlachetzki, J. C., Boktor, J. C., Cantu-Jungles, T. M., Thron, T., Zhang, M., Bostick, J. W., Khazaei, T., Chilakala, S., Morais, L. H., et al. (2022) · eLife · doi:10.7554/elife.81453 · Cited by 82
Self-citationGuo, T.-T., Zhang, Z., Sun, Y., Zhu, R.-Y., Wang, F.-X., Ma, L.-J., Jiang, L., & Liu, H.-D. (2023) · Nutrients · doi:10.3390/nu15040930 · Cited by 82
Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 91
Self-citationBile acid receptors and signaling crosstalk in the liver, gut and brain
Ferrell, J. M., & Chiang, J. Y. L. (2021) · Liver Research · doi:10.1016/j.livres.2021.07.002 · Cited by 72
Yadav, S., Dwivedi, A., Tripathi, A., & Tripathi, A. K. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.007 · Cited by 66
Zhao, Q., Chen, J., Wu, M., Yin, X., Jiang, Q., Gao, H., & Zheng, H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110638 · Cited by 49
Zhang, Y., Xu, S., Qian, Y., Mo, C., Ai, P., Yang, X., & Xiao, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1099018 · Cited by 51
Cavaliere, G., Catapano, A., Trinchese, G., Cimmino, F., Penna, E., Pizzella, A., Cristiano, C., Lama, A., Crispino, M., & Mollica, M. P. (2022) · Antioxidants · doi:10.3390/antiox12010004 · Cited by 52
Novel Pharmacotherapies in Parkinson’s Disease
Tizabi, Y., Getachew, B., & Aschner, M. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00375-5 · Cited by 43
Qiao, C.-M., Quan, W., Zhou, Y., Niu, G.-Y., Hong, H., Wu, J., Zhao, L.-P., Li, T., Cui, C., Zhao, W.-J., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03392-x · Cited by 45
Self-citationConvergent pathways of the gut microbiota–brain axis and neurodegenerative disorders
Gubert, C., Gasparotto, J., & Morais, L. H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac017 · Cited by 40
Xu, R.-C., Miao, W.-T., Xu, J., Xu, W. V., Liu, M.-R., Ding, S., Jian, Y.-X., Lei, Y.-H., Yan, N., & Liu, H.-D. (2022) · Nutrients · doi:10.3390/nu14194163 · Cited by 41
Catumbela, C. S. G., Giridharan, V. V., Barichello, T., & Morales, R. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00369-7 · Cited by 37
Lan, Z., Tang, X., Lu, M., Hu, Z., & Tang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26377 · Cited by 40
Targeting TREM2 for Parkinson’s Disease: Where to Go?
Li, X., & Zhang, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.795036 · Cited by 38
Self-citationValvaikar, S., Vaidya, B., Sharma, S., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105691 · Cited by 35
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 36
Mazzocchi, M., Goulding, S. R., Morales-Prieto, N., Foley, T., Collins, L. M., Sullivan, A. M., & O'Keeffe, G. W. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.02.025 · Cited by 32
Zhang, Y., Xu, S., Qian, Y., He, X., Mo, C., Yang, X., & Xiao, Q. (2022) · Brain Research · doi:10.1016/j.brainres.2021.147749 · Cited by 34
The emerging role of microbiota derived SCFAs in neurodegenerative disorders
Wachamo, S., & Gaultier, A. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101012 · Cited by 36
Yang, H., Li, S., & Le, W. (2022) · Aging and Disease · doi:10.14336/ad.2022.01281 · Cited by 32
Zamanian, M. Y., Terefe, E. M., Taheri, N., Kujawska, M., Tork, Y. J., Abdelbasset, W. K., Shoukat, S., Opulencia, M. J. C., Heidari, M., & Alesaeidi, . (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221005122408 · Cited by 30
Gut microbial production of imidazole propionate drives Parkinson’s pathologies
Park, H., Cheon, J., Kim, H., Kim, J., Kim, J., Shin, J., Kim, H., Ryu, G., Chung, I. Y., Kim, J. H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63473-4 · Cited by 28
Ravi, A., Umapathy, S., & Pan, I. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01609-2 · Cited by 34
Liu, J., Chen, Q., & Su, R. (2024) · Medicine · doi:10.1097/md.0000000000037960 · Cited by 25
Ji, L., Huang, T., Mao, L., Xu, Y., Chen, W., Wang, W., & Wang, L. (2023) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12745 · Cited by 24
Xin, Z., Xin, C., Huo, J., Liu, Q., Dong, H., Li, R., & Liu, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03988-x · Cited by 26
Wiefels, M. D., Furar, E., Eshraghi, R. S., Mittal, J., Memis, I., Moosa, M., Mittal, R., & Eshraghi, A. A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221003085508 · Cited by 25
Causal relationship between gut microflora and dementia: a Mendelian randomization study
Fu, J., Qin, Y., Xiao, L., & Dai, X. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1306048 · Cited by 25
Jia, X., Chen, Q., Zhang, Y., & Asakawa, T. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1296713 · Cited by 22
Role of histone deacetylase inhibitors in non-neoplastic diseases
Zhou, C., Zhao, D., Wu, C., Wu, Z., Zhang, W., Chen, S., Zhao, X., & Wu, S.-L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33997 · Cited by 24
Zhang, W., Dong, X., & Huang, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106787 · Cited by 22
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model
Sancandi, M., Caro, C. D., Cypaite, N., Marascio, N., Avagliano, C., Marco, C. D., Russo, E., Constanti, A., & Mercer, A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.986127 · Cited by 22
Duan, W.-X., Xie, W.-Y., Ying, C., Fen, W., Cheng, X.-Y., Mao, C.-J., Liu, J., & Liu, C.-F. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01029-5 · Cited by 21
Self-citationFeng, J., Hu, X., Liu, J., Wang, W., Chen, L., Pang, R., & Zhang, A. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1650807 · Cited by 20
Zhao, R., Mu, B., Wang, D., XinHuang, Ma, Q., & Lu, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04584-9 · Cited by 24
Missiego-Beltrán, J., Olalla-Álvarez, E. M., González-Brugera, A., & Beltrán-Velasco, A. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168998 · Cited by 19
Wang, Y., Chen, R., Shi, G., Huang, X., Li, K., Wang, R., Cao, X., Yang, Z., Zhao, N., & Yan, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01511 · Cited by 18
Wang, B., Pan, M., Yang, L., Xu, J., Ye, C., Li, Y., Gong, Q., Liu, C., Li, L., Qin, J., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01880-x · Cited by 17
Self-citationGuo, M., Gao, H., Wang, Y., & Xiang, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1574512 · Cited by 18
Xu, Y., Wen, L., Tang, Y., Zhao, Z., Xu, M., Wang, T., & Chen, Z. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1194 · Cited by 13
Feng, M., Zou, Z., Shou, P., Peng, W., Liu, M., & Li, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1479343 · Cited by 14
Self-citationSodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease
Avagliano, C., Caro, C. D., Cuozzo, M., Roberti, R., Russo, E., Rana, G. L., & Russo, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117903 · Cited by 17
Kong, X., Zhao, J. W., Gao, H., Wang, W., Wang, J., & Tan, X. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.103808 · Cited by 12
Sanluca, C., Spagnolo, P., Mancinelli, R., Bartolo, M. I. D., Fava, M., Maccarrone, M., Carotti, S., Gaudio, E., Leuti, A., & Vivacqua, G. (2024) · Metabolites · doi:10.3390/metabo14070352 · Cited by 9
Nohesara, S., Abdolmaleky, H. M., Thiagalingam, S., & Zhou, J. (2023) · Epigenomics · doi:10.2217/epi-2023-0342 · Cited by 20
Shang, M., Ning, J., Zang, C., Ma, J., Yang, Y., Jiang, Y., Chen, Q., Dong, Y., Wang, J., Li, F., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.011 · Cited by 9
O'Mahony, A. G., Mazzocchi, M., Morris, A., Morales‐Prieto, N., Guinane, C. M., Wyatt, S. L., Collins, L., Sullivan, A. M., & O’Keeffe, G. W. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110319 · Cited by 9
Cui, Y., Cen, Q., Feng, J., Wei, J., Wang, L., Chang, C., Pang, R., Wang, J., & Zhang, A. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01589-8 · Cited by 9
Therapeutic Potential of Sodium Butyrate in Neurological and Psychiatric Disorders
Rahmani, D., Chodari, L., Kakallahpour, M., & Niknam, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05428-w · Cited by 11
Kovács, A., Langin, L. M., González-Hernández, J. L., & Pearce, D. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12981-0 · Cited by 10
Du, J., Zhang, P., Tan, Y., Gao, C., Liu, J., Huang, M., Li, H., Shen, X., Huang, P., & Chen, S. (2024) · Movement Disorders · doi:10.1002/mds.29803 · Cited by 8
Jahan, S., Ikram, M. A., Siraj, S., Ullah, S., Zakria, M., & Ahmad, N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04762-3 · Cited by 11
Zang, Z., Yang, F., Qu, L., Ge, M., Tong, L., Xue, L., Sun, X., & Hai, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1640389 · Cited by 8
Zhu, H., He, H., Yang, M., Zhu, H., Hagiwara, A., Shu, L., Xu, J., Miao, Y., Han, X., & Wang, C. (2025) · iScience · doi:10.1016/j.isci.2025.114044 · Cited by 8
Unveiling Butyrate as a Parkinson’s Disease Therapy
Abreu, A. E., Empadinhas, N., & Cardoso, S. M. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01498-x · Cited by 7
Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder
Vashishth, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102466 · Cited by 8
The role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
Alexoudi, A., Kesidou, L., Gatzonis, S. D., Charalampopoulos, C., & Tsoga, A. (2023) · Cureus · doi:10.7759/cureus.49320 · Cited by 7
Bellitto, D., Bozzo, M., Ravera, S., Bertola, N., Rosamilia, F., Milia, J., Barboro, P., Vargas, G. C., Lisa, D. D., Pastorino, L., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103544 · Cited by 6
Kovács, A., González-Hernández, J. L., & Pearce, D. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-46283-w · Cited by 6
Chen, Y., Wang, D., Liao, Y., Zuo, G., & Lu, X. (2024) · Discover Medicine · doi:10.1007/s44337-024-00135-2 · Cited by 5
Li, X., Hao, X., Chen, C., Zhai, C., Pan, T., Zhou, X., Liu, Y., Wu, D., & Chen, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1421270 · Cited by 7
Self-citationAkkermania muciniphila: a rising star in tumor immunology
Wang, L., & Tang, D. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03493-6 · Cited by 5
Parkinson’s disease beyond the brain: implications for treatments
Naeini, S. M., Lopez, M. D., Fraser, P. E., & Tandon, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1600782 · Cited by 4
Gut Microbes in Parkinson's Disease
Markidi, A., Elford, J. D., Berkers, C. R., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00002-3 · Cited by 4
Zhang, H., Fan, C., Li, L., Liu, F., Li, S., Ma, L., Yang, Y., Cooper, D. N., Yang, Y., Hu, R., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01027-7 · Cited by 4
Xin, Z., Xin, C., Huo, J., Liu, Q., Dong, H., Li, X., Liu, Y., & Li, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123686 · Cited by 3
Self-citationOnaolapo, A. Y., Ojo, F. O., Olofinnade, A. T., Falade, J., Lawal, I. A., & Onaolapo, O. J. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220903114559 · Cited by 4
Gong, X., Chen, Y., Chen, C., Chen, C., & Zhang, X. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107147 · Cited by 2
Self-citationAn, K., Qu, Y., Li, J., Wang, D., Mao, Z., & Xue, Z. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2558119 · Cited by 2
Roseburia intestinalis Offers Vagus-Dependent Neuroprotection Against Parkinson’s Disease
Li, M., Wu, J., Xiang, J., Yang, Z., Wang, B., Li, P., Zheng, M., Li, Y., Shao, X., & He, L. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05707-0 · Cited by 2
Liu, J., & Su, R. (2026) · PeerJ · doi:10.7717/peerj.20688 · Cited by 2
The neurobiology of fatty acids: Metabolism, signaling, and roles in neurodegenerative diseases
Rojas, R., Pellitero, A., Arslan, B., Pérez‐Samartín, A., & Matute, C. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2026.101378 · Cited by 4
Gao, Y., Lu, Y., Zhao, S., Chen, R., Liu, J., Zhang, S., Bai, X., & Zhang, J. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153503 · Cited by 2
Maternal microbiome-derived propionate regulates offspring myelination via histone lactylation
Zhang, Y., Han, B., Wang, X., Li, Y., Zou, Y.-R., Li, S.-H., Li, X., Li, Y.-B., Huang, Y., Sun, D.-Z., et al. (2026) · Brain · doi:10.1093/brain/awag034 · Cited by 2
Self-citationTchung, A., Even, A., & Trudeau, L. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.02.003 · Cited by 3
Du, Y., An, Y., Cao, Z., Xu, G., Chu, M., & Lu, Y. (2026) · Food & Function · doi:10.1039/d5fo03902a · Cited by 2
The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis
Saadh, M. J., Dhiaa, S. M., Bansal, P., Dabis, H. K., Katyal, A., Saraswat, V., Ibrahim, A. A., Kadem, R. U., & Ubaid, M. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-024-00292-9 · Cited by 2
Emerging Relationship Between the Gut Microbiota and Neurodegenerative Disorders
Iyer, S., Verma, S., Marathe, S. A., & Tare, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_11 · Cited by 2
Wang, Y., Liang, D.-L., Cao, R., Ruhan, A., Zeng, J.-F., Xu, B., Li, J., Zhang, W., Gao, L., Xiao, K., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05386-3 · Cited by 1
Gupta, D. K., & Kumar, R. (2026) · Cureus · doi:10.7759/cureus.103206 · Cited by 1
Devi, S., Debnath, N., Yadav, P., Satyavolu, S., Yadav, A. K., & Tyagi, N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70165 · Cited by 1
Tian, X., Zhang, R., Zhang, H., Liang, Y., Ma, Y., Yang, Z., & Han, F. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2685875 · Cited by 1
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Wang, Y., Jing, G., Fu, Y., Li, Y., & Wu, C. (2024) · Diseases & Research · doi:10.54457/dr.202401007 · Cited by 1
Xin, Z., Xin, C., Huo, J., Liu, Q., Dong, H., Li, R., & Liu, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-2061629/v1
Du, J., Huang, P., Zhang, P., Gao, C., Liu, J., Huang, M., Li, H., Shen, X., Tan, Y., & Chen, S. (2024) · Research Square · doi:10.21203/rs.3.rs-5182069/v1
Dairy consumption and the risk of Parkinson's disease
Hasan, R. S., & Forsan, H. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00010-5
Cai, A., Shen, D., Xiong, Q., Zhu, Y., Di, X., Yan, Y., Chen, Z., Yao, Q., Chen, R., Lin, G., et al. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01024-w
Chen, Y., Wei, X., Yi, X., & Jiang, D. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.020
Jia, W., Zheng, X., Kuang, J., Zhao, M., & Zhang, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31402-5.00009-8
Zheng, W., Xu, Q., Ren, M., Wang, Z., Wang, M., Gao, Y., Zhang, J., Zhang, M., & Chen, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116814
Self-citationKhodve, G., Raval, S., & Banerjee, S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.015
Metadata
- Authors
- Hou, Y., Li, X., Liu, C., Zhang, M., Zhang, X., Ge, S., & Zhao, L.
- Affiliations
- Beijing Advanced Innovation Center for Food Nutrition and Human Health (CN)
- China Agricultural University (CN)
- Beijing Technology and Business University (CN)
- Corresponding author
- Zhao, Liang
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 150
- Pages
- 111376
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W3159598422
- Cited by
- 101
- References
- 63
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 28 · 2023: 15 · 2022: 13 · 2021: 5
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (32072196)
- Beijing Science and Technology Planning Project (Z181100009318005)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- short-chain fatty acids, Parkinson's disease, MPTP-induced neurotoxicity, sodium butyrate, sodium acetate, sodium propionate, neuroprotection, dopaminergic neuron loss, substantia nigra pars compacta, neuroinflammation, microglial activation, alpha-synuclein, tyrosine hydroxylase, NF-κB signaling, MAPK signaling, gut microbiota metabolites, motor impairment
- MeSH terms
- Animals, Disease Models, Animal, Fatty Acids, Volatile, Mice, Inbred C57BL, Parkinson Disease, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroprotective Agents, MPTP Poisoning, Mice, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
